Biotech, Trinity

Trinity Biotech climbs after data for glucose monitoring device
Trinity Biotech (TRIB) stock gains on encouraging data from a pre-pivotal clinical trial for its next-gen continuous glucose monitoring ((CGM)) system. Read more here.
Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology
Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB),
Trinity Biotech Shares Rise After Update on Next-Gen Blood-Sugar Monitoring Device
Shares of Trinity Biotech climbed after the company released what it called compelling results from a study of its next-generation continuous glucose monitoring system, a device used for diabetes management that measures blood sugar levels in real time.
Trinity Biotech announces results from pre-pivotal trial for CGM system
Trinity Biotech (TRIB) announced results from its latest pre-pivotal clinical trial for its next-generation continuous glucose monitoring
Trinity Biotech announces breakthrough in CGM technology
DUBLIN - Trinity Biotech plc (NASDAQ:TRIB), an Ireland-based biotech firm with a market capitalization of $13.24 million, revealed promising results from a recent pre-pivotal clinical trial for its innovative continuous glucose monitoring (CGM) system.
Trinity Biotech faces US aid policy impact, PPP loan scrutiny
Trinity Biotech plc (NASDAQ:TRIB), an Ireland-based diagnostic company with a market capitalization of $23.7 million and current trading price of $1.32, is evaluating the potential effects of a recent ...
What's Going On With Trinity Biotech Shares Tuesday?
Trinity stock is trading higher on Tuesday after the company announced results from its pre-pivotal clinical trial for its ...
bovnews2d
Trinity Biotech’s (TRIB) Breakthrough Technology Shakes Up the Diabetes Market
But what exactly is driving this sudden attention towards Trinity Biotech, and how does it compare to broader market trends? Let’s explore. Trinity Biotech is a commercial-stage biotechnology company ...
Investing1mon
Trinity Biotech revises credit terms to boost liquidity
Trinity Biotech PLC (NASDAQ:TRIB), an Ireland-based diagnostic company with a market capitalization of $7.83 million, has announced an amendment to its credit agreement with Perceptive Credit ...
Nasdaq1mon
Trinity Biotech plc American Depositary Shares (TRIB)
Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...
Stocktwits on MSN1d
TRIB, SLXN, STSS: Why Retail Chatter On 3 Nano-Cap Healthcare Stocks Exploded Over 6000%
Three nano-cap healthcare stocks drew massive attention from retail investors on Stocktwits Tuesday, though not all for ...
Trinity Biotech stock hits 52-week low at $0.74 amid challenges
Investors have been closely monitoring Trinity Biotech's financial health and market position, as the company grapples with the headwinds that have led to this decline. With a significant debt burden ...